[Expression and Clinical Significance of CaMKIIγ in Patients with Acute Myeloid Leukemia]

Ming-Kai Liu1, Xu Dai1, Xiao-Ying Zhao1

  • 1Department of Laboratory Medicine, The First Affiliated Hospital of Shihezi University, Shihezi 832008, Xinjiang Uygur Autonomous Region, China.

Abstract

Insights

Calcium/calmodulin-dependent protein kinase II gamma (CaMKIIγ) is upregulated in acute myeloid leukemia (AML) patients, acting as a potential biomarker and therapeutic target. Its elevated expression correlates with poor prognosis and may involve the AKT/STAT5 pathway.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Context:

  • Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy with complex molecular underpinnings.
  • Understanding novel molecular markers and pathways is crucial for improving AML diagnosis and treatment.
  • Calcium/calmodulin-dependent protein kinase II gamma (CaMKIIγ) role in AML pathogenesis is not well-defined.

Purpose:

  • To investigate the expression levels of CaMKIIγ in AML patients.
  • To assess the diagnostic and prognostic value of CaMKIIγ in AML.
  • To explore the potential molecular mechanisms underlying CaMKIIγ's role in AML, including its association with signaling pathways like AKT/STAT5.

Summary:

  • CaMKIIγ expression was significantly upregulated in peripheral blood mononuclear cells of 90 AML patients compared to controls.
  • CaMKIIγ demonstrated diagnostic potential as a biomarker for AML and correlated with white blood cell count and FLT3-ITD mutation.
  • Inhibition of phosphorylated CaMKIIγ reduced pAKT and pSTAT5 expression, suggesting its involvement in the AKT/STAT5 signaling pathway crucial for AML progression.

Impact:

  • CaMKIIγ serves as a potential prognostic marker and therapeutic target in AML.
  • The findings suggest CaMKIIγ contributes to AML development and progression via the AKT/STAT5 pathway.
  • This research provides a foundation for developing targeted therapies aimed at CaMKIIγ in AML treatment strategies.

Related Concept Videos

Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.4K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.3K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.2K